TPI
TrumpEconomyImmigrationCrimeCongressHealthcareCourts
Subscribe
TPI
The Political Insider
thepoliticalinsider.com|Privacy Policy|Contact|© 2026 The Publisher Desk

Trump Speeds Psychedelics Review, Including Ibogaine

April 18, 2026·17 days ago·via CNBC
Trump Speeds Psychedelics Review, Including Ibogaine
Trump signs an order to speed FDA review of psychedelics, spotlighting the controversial drug ibogaine for potential breakthroughs against addiction and trauma. Ditching timid regulation, he champions American pioneers ready to heal our nation without socialist safety nets that stifle progress. This targets real crises like the opioid mess liberals exacerbated, putting sovereignty over FDA fiefdoms. Trump delivers hope where bureaucrats peddle despair. Read more about this...

Related Coverage

WebsiteTrump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs — Fox News Politics
WebsiteRED FLAG: FBI says these apps let China suck up your personal data — The Blaze
SubstackGasBuddy Expert Warns: This Oil Crisis Could Last Over a Year (w/ Patrick De Haan) — The Bulwark
WebsiteTrump Signs Executive Order Speeding Up Research On Using Psychedelics For Mental Health — Daily Caller
WebsiteTrump signs order to fast track psychedelic drug research to treat veterans with PTSD — New York Post
WebsiteWe keep talking about Jesus. We refuse to define Him. — The Blaze
WebsiteTrump Cuts Wait For Breakthrough Mental Health Treatments For Veterans — Daily Wire